Betsy Hanna - May 17, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Director
Signature
/s/ Lisa Taylor as Attorney-in-fact for Betsy Hanna
Stock symbol
TMCI
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 08:39 PM
Previous filing
Oct 4, 2021
Next filing
May 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +1.19K $0.00 1.19K May 17, 2022 Direct F1
transaction TMCI Common Stock Award $0 +2.3K +193.34% $0.00 3.48K May 17, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +8.6K $0.00 8.6K May 17, 2022 Common Stock 8.6K $15.80 Direct F3
transaction TMCI Stock Option (Right to Buy) Award $0 +16.6K $0.00 16.6K May 17, 2022 Common Stock 16.6K $15.80 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting May 17, 2023 such that the RSUs will be fully vested on May 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Represents RSUs for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date.
F3 The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on June 17, 2022 such that the stock option will be fully vested and exercisable on May 17, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date.